After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
EyePoint Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of EyePoint Pharmaceuticals Inc is $617.62M. A total of 1.69 million shares were traded on the day, compared to an average of 640.12K shares.
In the most recent transaction, ANTHONY P. ADAMIS bought 67,100 shares of EYPT for 10.04 per share on Oct 23 ’24. In a previous transaction on Oct 14 ’24, David R. Guyer bought 36,975 shares at 8.92 per share.
Among the insiders who bought shares, DICICCO WENDY F acquired of 2,567 shares on Aug 20 ’24 at a per-share price of $7.79. This resulted in the Director holding 9,967 shares of EYPT after the transaction. In another insider transaction, ANDO GORAN bought 5,000 shares at $7.95 per share on Aug 21 ’24. Company shares held by the Director now total 13,150.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, EYPT has a high of $30.99 and a low of $5.67.
As of this writing, EYPT has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of -$0.4 per share and a lower estimate of -$0.69. The company reported an EPS of -$0.33 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. EYPT’s latest balance sheet shows that the firm has $211.56M in Cash & Short Term Investments as of fiscal 2021. There were $39.20M in debt and $23.66M in liabilities at the time. Its Book Value Per Share was $4.38, while its Total Shareholder’s Equity was $184.38M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EYPT is Buy with a score of 5.00.
